المؤلفون: Frede Donskov, C. Kollmansberger, D. S. Ernst, N. Agarwal, Simon Yuen Fai Fu, Takeshi Yuasa, Ajjai Alva, Aaron R. Hansen, Lori Wood, B. Beuselinck, J.C. Wells, Jeffrey Graham, Tri Le, Igor Stukalin, Ian D. Davis, Toni K. Choueiri, Ravindran Kanesvaran, Sandy Srinivas, Daniel Y.C. Heng, G. A. Bjarnason

المصدر: Stukalin, I, Wells, J C, Graham, J, Yuasa, T, Beuselinck, B, Kollmansberger, C, Ernst, D S, Agarwal, N, Le, T, Donskov, F, Hansen, A R, Bjarnason, G A, Srinivas, S, Wood, L A, Alva, A S, Kanesvaran, R, Fu, S Y F, Davis, I D, Choueiri, T K & Heng, D Y C 2019, ' Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium ', Current Oncology, vol. 26, no. 2, e175-179 . https://doi.org/10.3747/co.26.4595
Stukalin, I, Wells, J C, Graham, J, Yuasa, T, Beuselinck, B, Kollmansberger, C, Ernst, D S, Agarwal, N, Le, T, Donskov, F, Hansen, A R, Bjarnason, G A, Srinivas, S, Wood, L A, Alva, A S, Kanesvaran, R, Fu, S Y F, Davis, I D, Choueiri, T K & Heng, D Y C 2019, ' Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma : Results from the international metastatic renal cell carcinoma database consortium ', Current Oncology, vol. 26, no. 2, pp. e175-e179 . https://doi.org/10.3747/co.26.4595
Current Oncology
Volume 26
Issue 2
Pages 4595-179

مصطلحات موضوعية: Male, Databases, Factual, Cabozantinib, Pyridines, Renal cell carcinoma, metastatic, medicine.drug_class, medicine.medical_treatment, Kaplan-Meier Estimate, computer.software_genre, Tyrosine-kinase inhibitor, Targeted therapy, 03 medical and health sciences, chemistry.chemical_compound, Antineoplastic Agents, Immunological, 0302 clinical medicine, cabozantinib, Renal cell carcinoma, medicine, Humans, Anilides, 030212 general & internal medicine, Carcinoma, Renal Cell, Protein Kinase Inhibitors, Aged, nivolumab, Database, Proportional hazards model, business.industry, Hazard ratio, targeted therapy, medicine.disease, Kidney Neoplasms, Confidence interval, Treatment Outcome, chemistry, 030220 oncology & carcinogenesis, Metastatic, Original Article, Female, Nivolumab, business, checkpoint inhibitors, computer

وصف الملف: Print-Electronic; application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d1fef38cd5bbc5502cb5ac5fb6c9802
https://doi.org/10.3747/co.26.4595

المؤلفون: David F. McDermott, Frede Donskov, Michael B. Atkins, Jahangeer Malik, Scott S. Tykodi, M.A. Climent Duran, J-L. Lee, Teresa Alonso-Gordoa, M.D. Kochenderfer, Niels Viggo Jensen, Rustem Gafanov, J. Burgents, Poul F. Geertsen, Karla Rodriguez-Lopez, H. Liu, J.M.G. Larkin, G. A. Bjarnason, Daniel C. Cho, Alexandr Poprach, C. Di Simone

المصدر: Annals of Oncology. 32:S687

مصطلحات موضوعية: Oncology, 0303 health sciences, medicine.medical_specialty, business.industry, Hematology, Pembrolizumab, medicine.disease, 03 medical and health sciences, Clear cell renal cell carcinoma, 0302 clinical medicine, First line therapy, 030220 oncology & carcinogenesis, Internal medicine, Cohort, Medicine, business, 030304 developmental biology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::837560663bcae5474c660ec97681c746
https://doi.org/10.1016/j.annonc.2021.08.058

المؤلفون: Tamim Niazi, Anand Swaminath, Sareh Keshavarzi, Eric Winquist, Arbind Dubey, Samir Patel, Patrick Cheung, Hany Soliman, D.Y.C. Heng, Scott C. Morgan, F. Pantenaude, Arjun Sahgal, William Chu, Belal Ahmad, P. Czaykowsky, G. A. Bjarnason, Raimond Wong, Justin White, Scott North, Gerald Lim

المصدر: International Journal of Radiation Oncology*Biology*Physics. 108:S27-S28

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Radiation, medicine.drug_class, business.industry, Metastatic kidney cancer, Tyrosine-kinase inhibitor, Stereotactic radiotherapy, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, Multi centre, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e1b6101a7d39953ee8aa1c35cc7d681f
https://doi.org/10.1016/j.ijrobp.2020.07.2121

المؤلفون: Alan So, Stephen A. Boorjian, G. A. Bjarnason, Pierre I. Karakiewicz, Christian Kollmannsberger, Luke T. Lavallée, Michael A.S. Jewett, Anil Kapoor, Wassim Kassouf, Patrick O. Richard, Ricardo A. Rendon, Aly-Khan A. Lalani, Lori Wood, Stephen E. Pautler, Nicholas Power, Jean-Baptiste Lattouf, Simon Tanguay, Ross J. Mason, Rodney H. Breau, Ilias Cagiannos, Naveen S. Basappa

المصدر: Canadian Urological Association Journal. 13

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Urology, medicine.medical_treatment, Consensus Statement, 030232 urology & nephrology, MEDLINE, Disease, medicine.disease, Systemic therapy, Immune checkpoint, Nephrectomy, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Renal cell carcinoma, 030220 oncology & carcinogenesis, Internal medicine, medicine, business, Kidney cancer

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30bb081eef5ec30656e2ce66b7b5e2fb
https://doi.org/10.5489/cuaj.5786

المؤلفون: M. Iafolla, U. Vaishampayan, J.C. Wells, Lynn Huynh, W.Y. Cheng, F. Donskov, B. McGregor, Rose Chang, Daniel Y.C. Heng, Giovanni Zanotti, John A. Steinharter, J. Graham, Mei Sheng Duh, G. A. Bjarnason, A. Hansen

المصدر: Value in Health. 22:S59-S60

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Sunitinib, Health Policy, First line, Public Health, Environmental and Occupational Health, medicine.disease, Risk model, Renal cell carcinoma, Internal medicine, Clinical heterogeneity, Medicine, business, Intermediate risk, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::2e2f5de7655c459f34a598b59d433308
https://doi.org/10.1016/j.jval.2019.04.146

المؤلفون: Neeraj Agarwal, G. A. Bjarnason, Jennifer J. Knox, Takeshi Yuasa, J. J. Ko, Lori Wood, Min-Han Tan, Lauren C. Harshman, Sandy Srinivas, Toni K. Choueiri, Brian I. Rini, Aristotle Bamias, Nils Kroeger, Mary J. MacKenzie, Sumanta K. Pal, Sun Young Rha, Daniel Y. Heng, Ulka N. Vaishampayan, J.-L. Lee, Frede Donskov

المصدر: British Journal of Cancer
Ko, J J, Choueiri, T K, Rini, B I, Lee, J-L, Kroeger, N, Srinivas, S, Harshman, L C, Knox, J J, Bjarnason, G A, MacKenzie, M J, Wood, L, Vaishampayan, U N, Agarwal, N, Pal, S K, Tan, M-H, Rha, S Y, Yuasa, T, Donskov, F, Bamias, A & Heng, D Y C 2014, ' First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC ', B J C, vol. 110, no. 8, pp. 1917-22 . https://doi.org/10.1038/bjc.2014.25

مصطلحات موضوعية: Male, Vascular Endothelial Growth Factor A, Oncology, Cancer Research, medicine.medical_specialty, mTOR inhibitor, overall survival, Population, Antineoplastic Agents, Context (language use), metastatic renal cell carcinoma, Disease-Free Survival, Renal cell carcinoma, Internal medicine, benchmarks, Carcinoma, medicine, Humans, international metastatic renal cell cancer database consortium, Molecular Targeted Therapy, Neoplasm Metastasis, education, Carcinoma, Renal Cell, Survival analysis, Aged, Proportional Hazards Models, Aged, 80 and over, Clinical Trials as Topic, education.field_of_study, Proportional hazards model, business.industry, TOR Serine-Threonine Kinases, Clinical study design, Middle Aged, medicine.disease, Survival Analysis, Surgery, outcomes assessment, Clinical trial, Treatment Outcome, targeted molecular therapy, Clinical Study, Female, business, progression-free survival, VEGF inhibitor

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7c53da20074d051bb32b5bf28fd77f3
https://doi.org/10.1038/bjc.2014.25

المؤلفون: Ulka N. Vaishampayan, Aaron R. Hansen, Benoit Beuselinck, Mei Sheng Duh, Krishnan Ramaswamy, Toni K. Choueiri, Giovanni Zanotti, Daniel Y. Heng, G. A. Bjarnason, Frede Donskov, G. De Velasco, Rana R. McKay, Rose Chang, Jeffrey Graham, J.C. Wells, Lynn Huynh

المصدر: Annals of Oncology. 29:viii315

مصطلحات موضوعية: biology, business.industry, Immune checkpoint inhibitors, VEGF receptors, Vascular Endothelial Growth Factor Receptor, 030232 urology & nephrology, Hematology, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, Oncology, Renal cell carcinoma, 030220 oncology & carcinogenesis, Cancer research, biology.protein, Medicine, business, Tyrosine kinase

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b2f855ed29b7089ed7e5c0fc7023f3a0
https://doi.org/10.1093/annonc/mdy283.098

المؤلفون: Takeshi Yuasa, Aristotle Bamias, Christian K. Kollmannsberger, Frede Donskov, J.-L. Lee, Carmel Pezaro, Felice Pasini, D.Y.C. Heng, Wanling Xie, Neeraj Agarwal, C. Porta, Christina Canil, H-W. Sim, Anna Paola Fraccon, T.K. Choueiri, Igor Stukalin, Ian D. Davis, G. A. Bjarnason, Ravindran Kanesvaran, J.C. Wells

المصدر: Annals of Oncology. 28:v311-v312

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, medicine.medical_treatment, Hematology, Disease, medicine.disease, Metastasis, Targeted therapy, Renal cell carcinoma, Internal medicine, medicine, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::3ec68bfbae22686c2730f817566290ac
https://doi.org/10.1093/annonc/mdx371.037

المؤلفون: Ulka N. Vaishampayan, Min-Han Tan, Daniel Y.C. Heng, Christian K. Kollmannsberger, G. A. Bjarnason, Mary J. MacKenzie, Jennifer J. Knox, Brian I. Rini, Husain K. Khambati, Scott North, Frede Donskov, Lori Wood, Toni K. Choueiri

المصدر: Khambati, H K, Choueiri, T K, Kollmannsberger, C K, North, S, Bjarnason, G A, Vaishampayan, U N, Wood, L, Knox, J J, Tan, M-H, MacKenzie, M J, Donskov, F, Rini, B I, Heng, D Y C & International mRCC Database Consortium 2014, ' Efficacy of targeted therapy for metastatic renal cell carcinoma in the elderly patient population ', Clinical Genitourinary Cancer (Online), vol. 12, no. 5, pp. 354-8 . https://doi.org/10.1016/j.clgc.2014.02.009

مصطلحات موضوعية: Sorafenib, Male, Niacinamide, Vascular Endothelial Growth Factor A, medicine.medical_specialty, Aging, Indoles, Databases, Factual, Urology, medicine.medical_treatment, Population, Antineoplastic Agents, urologic and male genital diseases, Antibodies, Monoclonal, Humanized, Article, Targeted therapy, Renal cell carcinoma, Internal medicine, medicine, Sunitinib, Humans, Pyrroles, Molecular Targeted Therapy, education, Carcinoma, Renal Cell, Protein Kinase Inhibitors, Aged, Retrospective Studies, Aged, 80 and over, education.field_of_study, business.industry, Phenylurea Compounds, Hazard ratio, Age Factors, Retrospective cohort study, medicine.disease, Confidence interval, Kidney Neoplasms, Surgery, Bevacizumab, Treatment Outcome, Oncology, Quinazolines, Female, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53c873379feeceb49c748c00c38e8427
https://pure.au.dk/portal/da/publications/efficacy-of-targeted-therapy-for-metastatic-renal-cell-carcinoma-in-the-elderly-patient-population(36083b14-3cd6-4066-a95d-65f6bee69e24).html

المؤلفون: Jennifer J. Knox, Piotr Czaykowski, Eric Winquist, G. A. Bjarnason, B. Boyd, D.Y.C. Heng, Anil Kapoor, Denis Soulières, Scott North, Robyn Jane Macfarlane, Aaron R. Hansen, Christian K. Kollmannsberger, Peter Venner, D.S. Ernst, Christina Canil, S.J. Hotte, Naveen S. Basappa, Pawel Zalewski, Lisa Wang

المصدر: Annals of Oncology. 28:v319

مصطلحات موضوعية: Oncology, medicine.medical_specialty, First line therapy, Pharmacokinetics, business.industry, Sunitinib, Internal medicine, Medicine, Hematology, business, Metastatic renal cell cancer, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a4f844bd91634cc8c7c3a468c957ce21
https://doi.org/10.1093/annonc/mdx371.054